A novel eye drop of alpha tocopherol to prevent ocular oxidant damage: improve the stability and ocular efficacy.
The aim of this study was to design novel mixed micelles as an ophthalmic delivery system for alpha-tocopherol (TOC) to prevent its degradation and improve ocular efficacy. The nonionic polymers, Polyoxyl 15 Hydroxystearate (Solutol® HS15) and Pluronic® F127, were discovered to be the most effective agents for retaining the activity and solubilization of TOC, respectively. Prepared by a thin-film hydration method, HS15/Pluronic® F127 yielded good encapsulation percentages of TOC, with a 27.7% drug loading efficiency. Incorporation of cetalkonium chloride (CKC) into HS15/Pluronic® F127 mixed micelles made the zeta potential of the micelles +17 mV, potentially prolonging the residence time of formulations on ocular surfaces. The optimized micelle preparation remained stable when diluted in a synthetic tear solution. It is known that the antioxidant ability of TOC in typical formulations reduces to around 85% of its initial value after 1 month when stored at 4 or 25 °C under an air atmosphere, which limits ophthalmic applications to less than 1 month. However, encapsulated TOC in investigated micelles remained stable for at least 6 months when sealed with N2. Finally, the cationic micelles were well tolerated after multiple administrations in rabbits, and they improved ocular accumulation of TOC. Taken together, these data suggest that the optimized micelle preparations described in this study may be suitable drug carriers for the treatment of ocular oxidant damage.
a School of Pharmacy, Shenyang Pharmaceutical University , Shenyang , P.R. China .|b Department of Pharmacy , The Second Affiliated Hospital, Harbin Medical University , Harbin , P.R. China , and.
Jiayu
J
Xin
c School of Pharmacy, Harbin Medical University , Harbin , P.R. China.
Jingling
J
Tang
a School of Pharmacy, Shenyang Pharmaceutical University , Shenyang , P.R. China .|b Department of Pharmacy , The Second Affiliated Hospital, Harbin Medical University , Harbin , P.R. China , and.
Meng
M
Bu
a School of Pharmacy, Shenyang Pharmaceutical University , Shenyang , P.R. China .
Yanhui
Y
Sun
a School of Pharmacy, Shenyang Pharmaceutical University , Shenyang , P.R. China .
Xinyu
X
Wang
b Department of Pharmacy , The Second Affiliated Hospital, Harbin Medical University , Harbin , P.R. China , and.
Linhua
L
Wu
a School of Pharmacy, Shenyang Pharmaceutical University , Shenyang , P.R. China .
Hongzhuo
H
Liu
D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage* / Q000378:metabolism; D003315:Cornea / Q000187:drug effects* / Q000378:metabolism; D004337:Drug Carriers / Q000008:administration & dosage / Q000378:metabolism; D004355:Drug Stability; D008297:Male; D008823:Micelles; D009883:Ophthalmic Solutions / Q000008:administration & dosage* / Q000378:metabolism; D016877:Oxidants / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011817:Rabbits; D024502:alpha-Tocopherol / Q000008:administration & dosage* / Q000378:metabolism
D000975:Antioxidants; D004337:Drug Carriers; D008823:Micelles; D009883:Ophthalmic Solutions; D016877:Oxidants; D024502:alpha-Tocopherol
Alpha-tocopherol; antioxidant activity; cationic; eye drops; mixed micelles; ocular delivery